Skip to main content
[Preprint]. 2022 Mar 2:2022.03.01.22271582. [Version 1] doi: 10.1101/2022.03.01.22271582

Table 4.

Test validity of laboratory-based BinaxNow antigen testing compared to viral culture

Sub-Cohort Specimens Tested Sensitivity (95% CI) Specificity (95% CI)
Total 61 72% (16/22), (50–88%) 85% (33/39), (69–93%)
Delta 33 69% (9/13), (38–89%) 85% (17/20), (60–95%)
Omicron 28 78% (7/9), (36–96%) 84% (16/19), (59–95%)
Days 0–5 22 81% (13/16), (53–94%) 67% (4/6), (18–95%)
Days 6–10 39 50% (3/3), (11–89%) 88% (29/33), (71–96%)